Ortho Biotech, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
- Website
- http://www.orthobiotech.com
Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 4:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 4
2 (100.0%)Effect of Epoetin Alfa on Hemoglobin, Symptom Distress, and Quality of Life in Patients Receiving Chemotherapy
Phase 4
Completed
- Conditions
- ChemotherapyAnemiaCancer
- First Posted Date
- 2007-09-03
- Last Posted Date
- 2010-04-02
- Lead Sponsor
- Ortho Biotech, Inc.
- Target Recruit Count
- 273
- Registration Number
- NCT00524407
The Effect of PROCRIT (Epoetin Alfa) on Postoperative Vigor and Handgrip Strength (VIGOR Study)
Phase 4
Completed
- Conditions
- Anemia
- First Posted Date
- 2006-11-22
- Last Posted Date
- 2010-04-06
- Lead Sponsor
- Ortho Biotech, Inc.
- Target Recruit Count
- 289
- Registration Number
- NCT00401869
News
No news found